Table 2 |
|||||
| Selected clinicopathologic features of the brain tumors in this study | |||||
| Tumor | Age & sex | Tumor (cc) | Mitoses per 10 HPF | Ki67 positive tumor cells | |
| Pre Op | Post Op | ||||
| GBM1 | 50 yr M | 80.8 | 19.1 | 46.5 ± 6.4 | 61 % |
| GBM2 | 81 yr M | 51.4 | 0.0 | 19.5 ± 2.1 | 55 % |
| GBM3 | 52 yr F | 124.0 | 96.1 | 10 ± 2.8 | 38 % |
| GBM4 | 44 yr M | 35.6 | 0.0 | 18.5 ± 2.1 | Not tested |
| LCM1 | 55 yr M | 19.0 | 0.0 | 51.5 ± 9.2 | Not tested |
| LCM2 | 61 yr M | 6.5 | 0.0 | 64.5 ± 5.0 | Not tested |
| EP1 | 73 yr M | 20.6 | 1.38 | 0 | 10 % |
The volumes of tumor were provided as estimates by the neurosurgeon. HPF = high power field (400X).
Truong et al. Diagnostic Pathology 2012 7:66 doi:10.1186/1746-1596-7-66
